Financial & Tax Architects LLC Decreases Stock Position in Colgate-Palmolive (NYSE:CL)

Financial & Tax Architects LLC reduced its position in Colgate-Palmolive (NYSE:CL) by 93.8% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 3,754 shares of the company’s stock after selling 56,882 shares during the period. Financial & Tax Architects LLC’s holdings in Colgate-Palmolive were worth $341,000 at the end of the most recent reporting period.

A number of other hedge funds also recently added to or reduced their stakes in the company. Premier Path Wealth Partners LLC raised its holdings in Colgate-Palmolive by 11.4% in the 4th quarter. Premier Path Wealth Partners LLC now owns 3,240 shares of the company’s stock worth $295,000 after acquiring an additional 332 shares during the last quarter. Integrated Investment Consultants LLC grew its position in Colgate-Palmolive by 88.5% in the 4th quarter. Integrated Investment Consultants LLC now owns 25,566 shares of the company’s stock worth $2,324,000 after purchasing an additional 12,000 shares during the period. Arkadios Wealth Advisors grew its position in Colgate-Palmolive by 11.7% in the 4th quarter. Arkadios Wealth Advisors now owns 6,476 shares of the company’s stock worth $589,000 after purchasing an additional 678 shares during the period. Canoe Financial LP grew its position in Colgate-Palmolive by 5.0% in the 4th quarter. Canoe Financial LP now owns 88,646 shares of the company’s stock worth $8,059,000 after purchasing an additional 4,200 shares during the period. Finally, Folger Nolan Fleming Douglas Capital Management Inc. grew its position in Colgate-Palmolive by 6.1% in the 4th quarter. Folger Nolan Fleming Douglas Capital Management Inc. now owns 5,714 shares of the company’s stock worth $519,000 after purchasing an additional 330 shares during the period. 80.41% of the stock is currently owned by hedge funds and other institutional investors.

Colgate-Palmolive Price Performance

Shares of CL traded up $0.23 during midday trading on Friday, hitting $88.79. 5,149,874 shares of the company traded hands, compared to its average volume of 3,679,883. The firm has a 50 day moving average of $92.27 and a 200-day moving average of $97.78. Colgate-Palmolive has a 52 week low of $79.69 and a 52 week high of $109.30. The stock has a market cap of $72.55 billion, a price-to-earnings ratio of 25.44, a PEG ratio of 3.01 and a beta of 0.44. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.68 and a current ratio of 1.04.

Colgate-Palmolive Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st will be issued a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 2.25%. The ex-dividend date is Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 57.31%.

Insider Buying and Selling at Colgate-Palmolive

In related news, CFO Stanley J. Sutula III sold 45,410 shares of the stock in a transaction dated Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total value of $4,273,535.10. Following the completion of the transaction, the chief financial officer now owns 36,726 shares of the company’s stock, valued at approximately $3,456,283.86. This trade represents a 55.29 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 0.37% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have commented on the stock. Barclays cut their target price on shares of Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating for the company in a research report on Friday. Stifel Nicolaus cut their target price on shares of Colgate-Palmolive from $101.00 to $95.00 and set a “hold” rating for the company in a research report on Friday. Piper Sandler cut their price objective on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a research report on Monday, January 6th. Wells Fargo & Company cut their price objective on shares of Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a research report on Tuesday, January 7th. Finally, JPMorgan Chase & Co. cut their price objective on shares of Colgate-Palmolive from $109.00 to $103.00 and set an “overweight” rating for the company in a research report on Thursday. One investment analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have assigned a buy rating to the stock. According to MarketBeat, Colgate-Palmolive presently has an average rating of “Hold” and a consensus price target of $101.11.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.